Fresenius To Buy 51% Of Indonesia Drug Maker For Estimated $200 Million
This article was originally published in PharmAsia News
Executive Summary
Fresenius Kabi said it plans to buy a controlling interest in Indonesia's PT Ethica Industri Farmasi in a deal that could be worth as much as $200 million.